<b>3．Revision of Procedures for Appropriate Management of Revlimid</b><sup>®</sup> <b>and Pomalyst</b><sup>®</sup> （<b>RevMate</b><sup>®</sup>）<b>and Issues for the Future </b>
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.